Richard Aarnio

Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7) (2024)

EJNMMI Research

Alzghool Obada M., Aarnio Richard, Helin Jatta S., Wahlroos Saara, Keller Thomas, Matilainen Markus, Solis Junel, Danon Jonathan J., Kassiou Michael, Snellman Anniina, Solin Olof, Rinne Juha O., Haaparanta‑Solin Merja

(O2 Muu julkaisu )

SV2A PET shows hippocampal synaptic loss in cognitively unimpaired <i>APOE</i> ε4/ε4 homozygotes (2024)

Alzheimer's and Dementia

Snellman, Anniina; Tuisku, Jouni; Koivumäki, Mikko; Wahlroos, Saara; Aarnio, Richard; Rajander, Johan; Karrasch, Mira; Ekblad, Laura L.; Rinne, Juha O.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

New improved radiometabolite analysis method for [18F]FTHA from human plasma : a test-retest study with postprandial and fasting state (2024)

EJNMMI Research

Aarnio, Richard; Kirjavainen, Anna; Rajander, Johan; Forsback, Sarita; Kalliokoski, Kari; Nuutila, Pirjo; Milicevic, Zvonko; Coskun, Tamer; Haupt, Axel; Laitinen, Iina; Haaparanta-Solin, Merja

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (2024)

EJNMMI Research

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes : A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study (2024)

Diabetes Care

Latva-Rasku, Aino; Rebelos, Eleni; Tuisku, Jouni; Aarnio, Richard; Bhowmik, Achol; Keskinen, Helmi; Laurila, Sanna; Lahesmaa-Hatting, Minna; Pekkarinen, Laura; Isackson, Henrik; Kirjavainen, Anna K.; Koffert, Jukka; Heurling, Kerstin; Nummenmaa, Lauri; Ferrannini, Ele; Oldgren, Jonas; Oscarsson, Jan; Nuutila, Pirjo

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight (2023)

Obesity

Pekkarinen L., Kantonen T., Oikonen V., Haaparanta-Solin M., Aarnio R., Dickens A.M., von Eyken A., Latva-Rasku A., Dadson P., Kirjavainen A.K., Rajander J., Kalliokoski K., Rönnemaa T., Nummenmaa L., Nuutila P.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation (2022)

EJNMMI Research

Vainio SK, Dickens AM, Matilainen M, Lopez-Picon FR, Aarnio R, Eskola O, Solin O, Anthony DC, Rinne JO, Airas L, Haaparanta-Solin M

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

[11C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue (2022)

European Journal of Nuclear Medicine and Molecular Imaging

Sun Lihua, Aarnio Richard, Herre Erika Atencio, Karna Salli, Palani Senthil, Virtanen Helena, Liljenback Heidi, Virta Jenni, Honkaniemi Aake, Oikonen Vesa, Han Chunlei, Laurila Sanna, Bucci Marco, Helin Semi, Yatkin Emrah, Nummenmaa Lauri, Nuutila Pirjo, Tang Jing, Roivainen Anne

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease - Study Protocol and Baseline Characteristics (2022)

Frontiers in Neurology

Snellman Anniina, Ekblad Laura L, Koivumäki Mikko, Lindgren Noora, Tuisku Jouni, Perälä Merja, Kallio Lila, Lehtonen Riina, Saunavaara Virva, Saunavaara Jani, Oikonen Vesa, Aarnio Richard, Löyttyniemi Eliisa, Parkkola Riitta Karrasch Mira, Zetterberg Henrik, Blennow Kaj, Rinne Juha O

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Quantification of the purinergic P2X(7) receptor with [C-11]SMW139 improves through correction for brain-penetrating radiometabolites (2022)

Journal of Cerebral Blood Flow and Metabolism

Brumberg J, Aarnio R, Forsberg A, Marjamaki P, Kerstens V, Moein MM, Nag S, Wahlroos S, Kassiou M, Windhorst AD, Halldin C, Haaparanta-Solin M, Fazio P, Oikonen V, Rinne JO, Varrone A

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Publications

Sort by:

Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7) (2024)

SV2A PET shows hippocampal synaptic loss in cognitively unimpaired <i>APOE</i> ε4/ε4 homozygotes (2024)

New improved radiometabolite analysis method for [18F]FTHA from human plasma : a test-retest study with postprandial and fasting state (2024)

Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (2024)

SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes : A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study (2024)

Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight (2023)

Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation (2022)

[11C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue (2022)

ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease - Study Protocol and Baseline Characteristics (2022)

Quantification of the purinergic P2X(7) receptor with [C-11]SMW139 improves through correction for brain-penetrating radiometabolites (2022)